Antibiotic resistance tends to stabilize over time, according to a study published in the open-access journal PLOS Pathogens ...
Streptococcus pneumoniae is a bacterium commonly found in the upper respiratory tract of humans. While it can exist ...
Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new ...
MSD has received approval from the European Commission (EC) for Capvaxive, a pneumococcal 21-valent conjugate vaccine, to ...
The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...
Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults: Rahway, New Jersey Friday, March 28, 2025, 09: ...